Evidence map›Paper›PMID 41966266›Full record

ArticleThe Journal of biological chemistry2026

Cleavage of histone H2A during embryonic stem cell differentiation destabilizes nucleosomes to counteract gene activation.

Mariel Coradin, Elizabeth G Porter, Francisca Nathalia Vitorino, Richard M Searfoss, Joseph Cesare, Yemin Lan, Zhexin Zhu, Peder J Lund, Simone Sidoli, Yekaterina Perez and 4 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Histone Tail Cleavage as a Mechanism for Epigenetic Regulation.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mariel CoradinBiochemistry and Molecular Biophysics Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Elizabeth G PorterEpigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA.
Francisca Nathalia VitorinoDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA.
Richard M SearfossDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA.
Joseph CesareEpigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Yemin LanDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Zhexin ZhuDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Peder J LundEpigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA.
Simone SidoliEpigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Molecular Biophysics Washington University in St Louis, St Louis, Missouri, USA.
Yekaterina PerezBiochemistry and Molecular Biophysics Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Congcong LuEpigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Justin BrumbaughDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder Colorado, USA.
Charles W M RobertsDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Benjamin A GarciaBiochemistry and Molecular Biophysics Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA. Electronic address: bagarcia@wustl.edu.

Funding

Viral modulation of epitranscriptomic mechanismsR01AI118891 · NIAID · WASHINGTON UNIVERSITY · PI GARCIA, BENJAMIN A, WEITZMAN, MATTHEW D. · 2015 to 2025
$5.4M
Quantitative mass spectrometry for comprehending epigenetic mechanisms in a new underlying neurological developmental disorderR01HD106051 · NICHD · WASHINGTON UNIVERSITY · PI Benjamin A Garcia · 2022 to 2026
$2.6M
Development and Application of Chemical Biology Approaches for Understanding Protein ArginylationR01HL177113 · NHLBI · WASHINGTON UNIVERSITY · PI Benjamin A Garcia, Zongtao Lin · 2025 to 2026
$1.2M
NHLBI NIH HHS R01 HL177113NIAID NIH HHS R01 AI118891NICHD NIH HHS R01 HD106051
6 · The paper itself

Abstract

Histone proteolysis is an understudied phenomenon in which the N-terminal tails of histones are irreversibly cleaved by intracellular proteases. During development, histone post-translational modifications (PTMs) are known to orchestrate gene expression patterns that ultimately drive cell fate decisions. Therefore, deciphering the mechanisms of histone proteolysis is necessary to enhance the understanding of cellular differentiation. Here, we show that histone H2A is cleaved by the lysosomal protease Cathepsin L during mouse ESC differentiation. Using quantitative mass spectrometry (MS), we identified L23 to be the primary cleavage site that gives rise to the main clipped form of H2A (cH2A), which reaches a maximum level of ∼1% of total H2A after 4 days of ESC differentiation. Using ChIP-seq, we found that preventing proteolysis leads to an increase in acetylated H2A at promoter regions in differentiated ES cells. We also identified novel readers of different acetylated forms of H2A in pluripotent ES cells, such as members of the PBAF remodeling complex, and showed that H2A proteolysis abolishes this recognition. Analysis of the histone H3 PTM profiles of full-length (FL) H2A and cH2A containing nucleosomes demonstrates that cH2A is associated with marks found on active genes, consistent with ChIP-seq experiments. cH2A-containing nucleosomes are also less stable or turned over at faster rates than nucleosomes containing FL H2A. Altogether, our data suggest that proteolysis serves as an efficient mechanism to silence pluripotency genes and destabilize the nucleosome core particle.

Indexed as

Cell DifferentiationEmbryonic Stem CellsHistonesMouse Embryonic Stem CellsNucleosomesTranscriptional ActivationAnimalsCathepsin LMiceProtein Processing, Post-TranslationalProteolysisCathepsin LHistonesNucleosomesChIP-seqchromatin remodelerdifferentiationepigenetichistonemass spectrometryproteolysisproteomicsstem cell

Identifiers

PMID41966266
PMCPMC13156748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.